| Name | Title | Contact Details |
|---|
We are a biopharmaceutical company developing first-in-class therapies for cancer. Imetelstat, a novel, first-in-class telomerase inhibitor, is our product candidate in clinical development. Telomerase enables cancer cells to maintain telomere length, which provides them with the capacity for limitless cellular replication. Imetelstat is a potent and specific inhibitor of telomerase. Based on clinical data we obtained in late 2012, we may develop imetelstat to treat one or more hematologic myeloid malignancies such as myelofibrosis, or MF, myelodysplastic syndromes, or acute myelogenous leukemia.
Ratio Corp is a Pompano Beach, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Harbor Health Elder Service Plan is a Dorchester Center, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Train for Compliance is a Bellevue, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
The Elizabeth Center for Cancer Detection is a Los Angeles, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.